Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4,018 GBX | +0.44% | +2.63% | +27.11% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Mar. 22 | Touax: the share resists the downturn thanks to results | CF |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Marine Freight & Logistics
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.11% | 1.54B | C+ | ||
+6.96% | 27.23B | A- | ||
+36.05% | 25.67B | A- | ||
-16.52% | 22.84B | C | ||
+2.49% | 12.8B | B | ||
+5.36% | 11.17B | B- | ||
+8.82% | 9.91B | B- | ||
+10.92% | 10.16B | B | ||
+3.13% | 8B | - | ||
-19.31% | 8.03B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CKN Stock
- Ratings Clarkson PLC